# Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease

> **NCT01204528** · PHASE2,PHASE3 · COMPLETED · sponsor: **Danderyd Hospital** · enrollment: 36 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Zemplar

## Key facts

- **NCT ID:** NCT01204528
- **Lead sponsor:** Danderyd Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204528, "Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01204528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*